Literature DB >> 9300658

Recent advances in molecular genetics of glaucomas.

M Sarfarazi1.   

Abstract

Glaucomas are a heterogeneous group of eye conditions with manifestation from as early as birth to very late age of onset in life. The primary type of these conditions affecting children and juveniles are less frequent, but the prevalence of glaucomas affecting older people of > or = 70 years progressively rises to approximately 5%. The molecular genetics of three types of glaucoma have been the subject of investigation in the last few years. As a result, two loci (GLC3A and GLC3B) have been identified for primary congenital glaucoma, one locus (GLC1A) for juvenile-onset primary open angle glaucoma and a further two loci (GLC1B and GLC1C) for late-onset chronic open angle glaucoma. Early this year, the first set of mutations was described in the CYP1B1 (Cytochrome P4501B1) and TIGR (Trabecular meshwork Inducible Glucocorticoid Response Protein) genes for the GLC3A and GLC1A-linked families, respectively. The mapping of different types of glaucoma and mutation identification in these two genes are the focus of this review.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300658     DOI: 10.1093/hmg/6.10.1667

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  35 in total

1.  Identification of a single ancestral CYP1B1 mutation in Slovak Gypsies (Roms) affected with primary congenital glaucoma.

Authors:  M Plásilová; I Stoilov; M Sarfarazi; L Kádasi; E Feráková; V Ferák
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

2.  CYP1B1 mutation profile of Iranian primary congenital glaucoma patients and associated haplotypes.

Authors:  Fereshteh Chitsazian; Betsabeh Khoramian Tusi; Elahe Elahi; Heidar Amini Saroei; Mohammad H Sanati; Shahin Yazdani; Mohammad Pakravan; Navid Nilforooshan; Yadollah Eslami; Mohammad Ali Zare Mehrjerdi; Reza Zareei; Mahmood Jabbarvand; Ali Abdolahi; Ali R Lasheyee; Arash Etemadi; Behnaz Bayat; Mehdi Sadeghi; Mohammad M Banoei; Behnam Ghafarzadeh; Mohammad R Rohani; Akram Rismanchian; Yvonne Thorstenson; Mansoor Sarfarazi
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

Review 3.  Glaucoma genetics.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2008

Review 4.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

5.  Novel TIGR/MYOC mutations in families with juvenile onset primary open angle glaucoma.

Authors:  D Stoilova; A Child; G Brice; T Desai; M Barsoum-Homsy; N Ozdemir; L Chevrette; M F Adam; H J Garchon; R Pitts Crick; M Sarfarazi
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

6.  Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region.

Authors:  M Sarfarazi; A Child; D Stoilova; G Brice; T Desai; O C Trifan; D Poinoosawmy; R P Crick
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 7.  Prospects for genetic intervention in primary open-angle glaucoma.

Authors:  M K Wirtz; T S Acott; J R Samples; J C Morrison
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

8.  Apolipoprotein E polymorphisms and primary glaucoma in Saudis.

Authors:  Najwa Mohammed Al-Dabbagh; Nourah Al-Dohayan; Misbahul Arfin; Mohammad Tariq
Journal:  Mol Vis       Date:  2009-05-04       Impact factor: 2.367

9.  Screening of CYP1B1 and MYOC in Moroccan families with primary congenital glaucoma: three novel mutations in CYP1B1.

Authors:  Latifa Hilal; Soraya Boutayeb; Aziza Serrou; Loubna Refass-Buret; Hafsa Shisseh; Fatiha Bencherifa; Mohammed El Mzibri; Bouchra Benazzouz; Amina Berraho
Journal:  Mol Vis       Date:  2010-07-02       Impact factor: 2.367

10.  Prevalence of open angle glaucoma in accompanying first degree relatives of patients with glaucoma.

Authors:  Franciele Vegini; Natanael Figueiroa Filho; Raphael Furlan Lenci; Diogo Garcia Neto; Remo Susanna Junior
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.